#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leber's congenital amaurosis Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Bronchiolitis C3 glomerulopathy Porphyria non-acute Mantle cell lymphoma Cushing's syndrome Epileptic encephalopathy Short stature Paraneoplastic neurological syndrome Partial lipodystrophy Hodgkin's disease recurrent Transplant rejection Thrombocytopenia Pulmonary tuberculosis More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I – Diagnostics Systemic sclerosis pulmonary – Basic Information Turner’s syndrome – Treatment Indolent systemic mastocytosis – Trials in Disease Rhabdoid tumour Fragile X syndrome – Diagnostics Myxofibrosarcoma – Basic Information Fragile X syndrome – Trials in Disease Fragile X syndrome – Basic Information Mantle cell lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AMMONIUM (15N) CHLORIDE Estradiol Valerate Ethambutol Ddcart‐Cd19 Sabirnetug Zongertinib Imipenem Anhydrate Midostaurin Lasofoxifene Argipressin Prasugrel Dantrolene Sodium LTG-001 Dabigatran Testosterone Undecanoate Alpelisib Purified Egg Phospholipids Saline IADADEMSTAT Mitapivat More therapies…

    Learn about Your Condition

    Migraine Pigmentary glaucoma Glomerulonephritis membranous Foot deformity Post-traumatic headache Habitual abortion Allergic respiratory disease Aneurysm ruptured Hydrocephalus Diabetic nephropathy Ophthalmoplegia Diminished ovarian reserve Infantile spasms Non-small cell lung cancer Staphylococcal infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Potassium Canrenoate and Trometamol on Blood Flow in Brain-Dead Organ Donors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Organ donor
    Investigated Drugs:
    • Potassium Canrenoate
    • Trometamol
    • Sodium Chloride
    France

  • Study on Proactive Drug Monitoring with Secukinumab, Ixekizumab, or Guselkumab for Patients with Moderate-to-Severe Psoriasis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Ixekizumab
    • Secukinumab
    • Guselkumab
    Belgium

  • Study on Treating Solid Tumors with Genetically Modified T-Cells (IMA203, IMA203CD8) and Nivolumab for Patients with Recurrent or Refractory Conditions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Ima203Cd8
    • AUTOLOGOUS T-CELLS TRANSDUCED WITH THE LENTIVIRAL LV-R11KEA ENCODING T-CELL RECEPTOR TARGETING PATIENT-SPECIFIC TUMOR-ASSOCIATED ANTIGENS
    • Nivolumab
    Germany

  • Study on the Effects of Cerebrolysin and Sodium Chloride for Recovery in Patients with Moderate to Severe Traumatic Brain Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Craniocerebral injury
    Investigated Drugs:
    • Cerebrolysin Concentrate
    • Sodium Chloride
    Romania

  • Study on the Effectiveness and Safety of Tocilizumab and Adalimumab for Patients with Severe Uveitis in Behçet’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Behcet’s syndrome
    • Uveitis
    Investigated Drugs:
    • Adalimumab
    • Tocilizumab
    France

  • Study on Continuing or Stopping Imatinib in Patients with Advanced or Metastatic Gastrointestinal Stromal Tumors After 10 Years of Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrointestinal stromal tumour
    Investigated Drugs:
    • Imatinib Mesilate
    France
Previous Page
1 … 352 353 354 355 356 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!